Atlas Trials

A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects

Clinical trial NCT01548391 · UNKNOWN

Trial details

NCT number
NCT01548391
Sponsor
Biotoxtech Co., Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-03-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.